Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
Go back to Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study| Elite Pharmaceuticals, Inc. (AMEX: ELTP) | Delayed: 0.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.30 | 52 Week High | $0.42 | |||
| Open | $0.30 | 52 Week Low | $0.11 | |||
| Day High | $0.31 | P/E | N/A | |||
| Day Low | $0.28 | EPS | $-0.02 | |||
| Volume | 795,357 | |||||
